Coletiva de imprensa: anúncios do Governo SP - 17/12/2020
Date:
17/12/2020
O Governador João Doria anunciou a chegada, nesta quinta-feira (17), de 2 milhões de doses prontas da vacina contra o coronavírus, a Coronavac, desenvolvida em parceria com o Instituto Butantan. Trata-se do maior lote de vacinas que chega à América do Sul até o momento.
“A pressa pela vacina é a pressa pela vida. Todos os brasileiros de bem têm pressa. São Paulo, reafirmo aqui, começar...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Brazilian Health Surveillance Agency, Holidays, Epidemiological Monitoring, Clinical Trial, Phase III, Immunization Programs/organization & administration, Public-Private Sector Partnerships/organization & administration, Risk Groups, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Local Health Systems/organization & administration, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Masks, Social Isolation, Schools/standards, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech
Coletiva de imprensa: anúncios do Governo SP - 14/12/2020
Date:
14/12/2020
O Governador João Doria confirmou nesta segunda-feira (14) que o estudo clínico conclusivo da vacina do Instituto Butantan contra o coronavírus será divulgado no dia 23 de dezembro. A medida dá mais agilidade aos trâmites de certificação na Anvisa (Agência Nacional de Vigilância Sanitária) e demais órgãos internacionais de saúde.
“Os brasileiros querem agilidade, querem as vacinas ...
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Betacoronavirus/immunology, Epidemiological Monitoring, Immunization Programs/organization & administration, Brazilian Health Surveillance Agency, Clinical Trial, Phase III, Viral Vaccines/supply & distribution, Viral Vaccines/immunology, Healthy Volunteers, Governmental Research Institutes, Risk Groups, Police/organization & administration, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Pandemics/statistics & numerical data, Social Isolation, Masks, COVID-19, Plano São Paulo, Coronavac, Instituto Butantan, Sinovac Biotech
Coletiva de imprensa: anúncios da Saúde no combate ao Coronavírus
Date:
11/12/2020
Saiba mais em www.saopaulo.sp.gov.br/coronavirus/vacina
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Epidemiological Monitoring, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Risk Groups, Masks, Social Isolation, Local Health Systems/organization & administration, Healthcare Financing, Quarantine/organization & administration, Commerce/organization & administration, Carrier State/transmission, Brazilian Health Surveillance Agency, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech
Coletiva de imprensa: anúncios do Governo SP - 09/09/2020
Date:
09/09/2020
O Governador João Doria anunciou, nessa quarta-feira (9), que o Produto Interno Bruto (PIB) de São Paulo já alcança níveis semelhantes aos do início do ano, quando a economia ainda não sofria os impactos da pandemia do coronavírus. O desempenho positivo é reflexo de um amplo plano de investimentos do Governo de São Paulo para a retomada econômica até 2022, aliado às medidas de desoner...
See more details
Gross Domestic Product, Public Sector/economics, Pandemics/economics, Pandemics/prevention & control, Epidemiological Monitoring, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Betacoronavirus/immunology, Local Health Systems/organization & administration, Quarantine/organization & administration, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/immunology, Clinical Trial, Phase III, Healthy Volunteers, Health Personnel/organization & administration, Brazilian Health Surveillance Agency, Research Support as Topic/economics, Social Isolation, Masks, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Vaccine Potency, Pandemics/statistics & numerical data, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Polymerase Chain Reaction/statistics & numerical data, Sanitary Supervision, Risk Groups, COVID-19, Plano São Paulo, Doria, João, Coronavac, Instituto Butantan, Sinovac Biotech
